ArticleJournal of oncology2020

Tyrosine Kinase Inhibitors as a Treatment of Symptomatic CNS Metastases in Oncogene-Driven NSCLC.

Omer Gal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.